tiprankstipranks
Trending News
More News >
ALX Oncology Holdings (ALXO)
NASDAQ:ALXO
US Market

ALX Oncology Holdings (ALXO) Income Statement

Compare
428 Followers

ALX Oncology Holdings Income Statement

Last quarter (Q3 2025), ALX Oncology Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ALX Oncology Holdings's net income was $-22.14M. See ALX Oncology Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.18M
Gross Profit
$ -872.00K$ -836.00K$ 0.00$ -736.00K$ 107.00K
Operating Expenses
$ 142.47M$ 170.28M$ 127.44M$ 83.56M$ 43.77M
Depreciation and Amortization
$ 872.00K$ 836.00K$ 342.00K$ 51.00K$ 202.00K
EBITDA
$ -132.25M$ -158.40M$ -122.84M$ -83.42M$ -43.46M
Operating Income
$ -142.47M$ -170.28M$ -127.44M$ -83.56M$ -43.66M
Other Income/Expenses
$ 7.62M$ 9.47M$ 4.02M$ 71.00K$ -1.84M
Pretax Income
$ -134.85M$ -160.81M$ -123.42M$ -83.48M$ -45.50M
Net Income
$ -134.85M$ -160.81M$ -123.48M$ -83.46M$ -45.74M
Per Share Metrics
Basic EPS
$ -2.58$ -3.74$ -3.03$ -2.07$ -1.28
Diluted EPS
$ -2.58$ -3.74$ -3.03$ -2.07$ -1.28
Weighted Average Shares Outstanding
52.17M 42.99M 40.70M 40.31M 39.84M
Weighted Average Shares Outstanding (Diluted)
52.17M 42.99M 40.70M 40.31M 39.84M
Currency in USD

ALX Oncology Holdings Earnings and Revenue History